WIT Press


Risk Assessment For Pharmaceutical Products In The Environment

Price

Free (open access)

Paper DOI

10.2495/EHR050011

Volume

9

Pages

8

Published

2005

Size

282 kb

Author(s)

V. Popov, V. Tomenko, C. A. Brebbia, A. H. Piersma & M. Luijten

Abstract

Recently, a Specific Targeted Research Project (STREP), termed F&F, supported by the European Commission under the Sixth Framework Programme Priority 5 on Food Quality and Safety (Contract No. FOOD-CT-2004-513953, http://foodandfecundity.factlink.net) on \“Pharmaceutical products in the environment: Development and employment of novel methods for assessing their origin, fate and effects on human fecundity” has been established. The F&F project intends to integrate research groups from different disciplines (risk assessors managers, clinical epidemiologists, endocrinologist, biochemists, as well as experts in biochemical and chemical diagnostics) for a better understanding of the extent of the problem. Our part in the project focuses on evaluating the risk assessment of PPs in food and in the environment. This work will pinpoint study and summarize the RA of different PPs, their origin and their influence on fecundity. 1 Risk assessment for PPs in the environment The risk assessment part of the F&F project includes: 1. Identification of a platform of endocrine disrupting substances in the food on a regional basis within Europe; 2. Identification and assessment of other risk factors that may influence fecundity, including age, reproductive history, diet and nutrition, socioeconomic status, habits and lifestyle;

Keywords